(PharmaNewsWire.Com, July 17, 2021 ) The Growth of the Cell Dissociation Market is driven mainly by increasing prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies. The study involved four major activities in estimating the current size of the market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
According to the new market research report "Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026" published by MarketsandMarkets™, is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7% during the forecast period.
GROWTH DRIVER: Increasing R&D activities in biopharmaceutical companies;
Key players in the biopharmaceutical industry are focusing on R&D in various therapeutic areas to introduce new drugs in the market. For this, these companies are investing heavily in various research activities such as clinical trials, efficacy studies, and toxicity studies. The majority of these studies require tissue dissociation products in order to isolate cells from primary tissues.
Geographically; the cell dissociation market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2020, North America accounted for the largest share of the market. The large share of North America can can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the strong presence of major market players in this region.
Key Market Players;
Some of the major players operating in this market are Thermo Fishers Scientific(US), Merck KgaA (Germany), Roche Diagnostics (Switzerland), and Becton, Dickinson and Company (US). In 2020, Thermo Fishers Scientific held the leading position in the market. The company has a strong geographic presence across the US, Asia, Europe, Middle East and Africa, & the Americas. Moreover, the company’s strong brand recognition and comprehensive product portfolio in the cell dissociation market is its key strength. Merck KgaA held the second position in the market 2020.
Enzymatic dissociation products accounted for the larger share of the market in 2020
Based on the product, segmented Enzymatic dissociation products, Non-Enzymatic dissociation products and instruments. In 2020, the Enzymatic dissociation products segment accounted for the larger share of the cell dissociation market. The large share of this segment can be attributed increasing incidence of cell based research.
The connective tissue segment accounted for the largest market share in 2020
Based on the tissue, the cell dissociation market is segmented into connective tissues, epethilial tissues and other tissues (skeletal, muscles tissues). The connective tissues segment accounted for the largest market share in 2020. The increasing incidence attributed to cell based research and development in pharmaceutical and biotechnology companies.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
